Navigation Links
Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
Date:10/17/2007

Decision Facilitates European Trial Opening in 13 New Sites

BERKELEY HEIGHTS, N.J., Oct. 17 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that the French Health Products Safety Agency ("AFSSAPS") has granted authorization to open the Company's Phase 3 trial of Genasense(R) (oblimersen sodium) Injection, its lead anticancer compound, in patients with advanced melanoma. This authorization enables the opening of approximately 13 new investigative sites over the next 2-4 weeks.

Genta's Phase 3 trial, known as AGENDA, is a randomized, double-blind, placebo-controlled study in which patients are randomly assigned to receive Genasense plus dacarbazine (DTIC) or DTIC alone. AGENDA will accrue approximately 300 patients and will be conducted at approximately 100 sites worldwide, including North America, Europe and Australia. Accrual, which is currently ongoing, is currently expected to complete in the fourth quarter of 2008.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense evaluating its potential to treat various forms of cancer.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodi
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported ... 2015. "After reporting positive top-line ... pacritinib during the quarter, we have subsequently received positive ... excited by the potential opportunity for pacritinib to meet ... patients with myelofibrosis, specifically in the portion of patients ...
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today reported ... The net loss and the loss from operations for ... respectively, compared to $10.7 million and $8.8 million during ... 2015, Alexza had consolidated cash, cash equivalents, marketable securities, ... continue to focus on ways in which to drive ...
(Date:5/6/2015)... 2015 The Parenteral Drug Association (PDA) Board ... with Richard M. Johnson to continue as ... very pleased to have Richard Johnson continue ... , the Chair of the Board of Directors. "Under ... Richard has led a strong staff and dedicated volunteers, ...
Breaking Medicine Technology:CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2
... , Study Discussed at the American Podiatric Medical ... Md., July 30 Foot complications, such as open wounds and ulcers, ... treat. However, a new wound dressing powder, which acts very much ... and reduce the amount of pain that a patient suffering from a ...
... , PHILADELPHIA, July 29 Pediatric researchers ... the development of type 2 diabetes also predisposes children to having ... genetic influence on how prenatal events may set the stage for ... Researchers from The Children,s Hospital of Philadelphia and the University ...
Cached Medicine Technology:New Powder Speeds Healing of Difficult Foot Wounds 2Diabetes Gene Raises Odds of Lower Birth Weight 2Diabetes Gene Raises Odds of Lower Birth Weight 3
(Date:5/7/2015)... (PRWEB) May 07, 2015 Over a lifetime, ... A broken tooth or a failing crown usually means a ... dentist result in more needle pokes to the gums, ... the new crown is fabricated. In addition, it takes time ... time than necessary. In the dental chair, Dr. Leonard Umanoff, ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini ... men from Southern China, it is becoming apparent to people ... for them. This is especially true for High Net Worth ... attention through the property they own, the schools their children ... those individuals, families and companies that are at higher risk ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, ... at Raymond James Stadium for all the “Bucs Babies” celebrating ... drafted into the “Bucs Babies” program last year. , ... children, particularly those born at the Florida Hospitals here in ... I really enjoyed my time participating in the festivities, interacting ...
(Date:5/6/2015)... Sulphur Springs, Texas (PRWEB) May 06, 2015 ... the stages of the HIMSS EMR Adoption Model, ... remove paper, improve patient engagement and automate processes. ... had transitioned from paper-driven to electronic workflows, patient ... to hard copies of consents. With HIMSS Stage ...
(Date:5/6/2015)... 2015 Experienced Vancouver air conditioning installation ... that they will now conduct their cooling services, including ... addition to commercial and residential units. Strata complex air ... lot of technical knowledge as well as a professionally ... we will take away any old air conditioning unit ...
Breaking Medicine News(10 mins):Health News:Dr. Leonard Umanoff, DDS Uses New CEREC Crowns that Save Time for Dental Patients 2Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2
... ... Nevada will highlight the fundamentals of the Federal and California False Claims Acts at a ... Association (NCMA). The meeting will be from 11:30 - 1:30 at the La Boheme ... ...
... , WASHINGTON , Feb. 15 ... Census Bureau: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , ... Profile America — Monday, February 15th .  On ... the first American to win the women,s World Figure Skating Championship, ...
... of the Journal of Clinical Sleep Medicine shows ... increase the risk of motor vehicle accidents in adolescents. ... have had a crash if they experienced sleepiness while driving ... (OR = 1.9). Eighty of the 339 students had ...
... Training ... Africa , ... Luanda, Angola (PRWEB) February 15, 2010 -- Top global companies and the President’s ... training program to arm the country’s malaria fighters with state-of-the-art mosquito surveillance and vector ...
... 14 Local businesses and the Change Your ... the Susan G. Komen for the Cure, Phoenix Affiliates on ... "Change Your Game! Day" will be comprised of a ... Golf Course, 1125 East Rio Salado Parkway, and Tempe Marketplace, 2000 ...
... therapeutic targets for patients with the cystic fibrosis, a ... School of Medicine has identified a defective signaling pathway ... in the journal Nature Medicine , the researchers ... peroxisome proliferator-activated receptor-γ (PPAR-γ) accounts for a portion of ...
Cached Medicine News:Health News:Nevada Qui Tam Attorney Tim Terry to Address Sacramento Gold Rush Chapter of the National Contract Management Association (NCMA) 2Health News:U.S. Census Bureau Daily Feature for Feb. 15 2Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 2Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 3Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 4Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 5Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 6Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 3Health News:Defective signaling pathway sheds light on cystic fibrosis 2
... BD Cell-Tak™ Cell and Tissue Adhesive ... from Mytilus edulis (marine mussel). These proteins ... secreted by the mussel to anchor itself ... BD Cell-Tak Cell and Tissue Adhesive is ...
... GE Healthcare is known ... best-in-class analysis programs for ... monitoring device. With advanced ... Gender-Specific, and ACI-TIPI, GE ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... a small bench top chemistry analyzer that utilizes ... strips with results available within 8 - 15 ... The instrument accepts whole blood samples and is ... card. At the conclusion of testing, results are ...
Medicine Products: